Return On Assets of Landos Biopharma, Inc. from 30 Sep 2021 to 31 Mar 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Landos Biopharma, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2021 to 31 Mar 2024.
  • Landos Biopharma, Inc. Return On Assets for the quarter ending 31 Mar 2024 was -63%, a 5.5% decline year-over-year.
  • Landos Biopharma, Inc. annual Return On Assets for 2023 was -49%, a 28% increase from 2022.
  • Landos Biopharma, Inc. annual Return On Assets for 2022 was -68%, a 89% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Landos Biopharma, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q1 2024 -63% -3% -5.5% 01 Jan 2024 31 Mar 2024
Q4 2023 -49% +19% +28% 01 Oct 2023 31 Dec 2023
Q3 2023 -45% +33% +42% 01 Jul 2023 30 Sep 2023
Q2 2023 -48% +23% +32% 01 Apr 2023 30 Jun 2023
Q1 2023 -60% -16% -35% 01 Jan 2023 31 Mar 2023
Q4 2022 -68% -32% -89% 01 Oct 2022 31 Dec 2022
Q3 2022 -78% -45% -139% 01 Jul 2022 30 Sep 2022
Q2 2022 -71% 01 Apr 2022 30 Jun 2022
Q1 2022 -44% 01 Jan 2022 31 Mar 2022
Q4 2021 -36% 01 Oct 2021 31 Dec 2021
Q3 2021 -33% 01 Jul 2021 30 Sep 2021

Landos Biopharma, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 -49% +19% +28% 01 Jan 2023 31 Dec 2023
2022 -68% -32% -89% 01 Jan 2022 31 Dec 2022
2021 -36% 01 Jan 2021 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.